Firas S Attar, A. Almayyahi, Ibrahim Mahjar Tuama Flayyih
{"title":"坦索罗辛在巴士拉总医院输尿管支架相关症状治疗中的作用","authors":"Firas S Attar, A. Almayyahi, Ibrahim Mahjar Tuama Flayyih","doi":"10.33762/bsurg.2019.164510","DOIUrl":null,"url":null,"abstract":"This study aimed to evaluate the efficacy of tamsulosin which is an α 1-blocker as a therapeutic agent to alleviate ureteral stent related symptoms. Seventy-two patients were included in this prospective study from August 2018 to August 2019 in Basrah Teaching Hospital. All patients underwent ureteroscopic management of ureteral stones and ureteral stent had been inserted for about one month period. Patients were divided into two groups; a tamsulosin group, and a control group. Then the International Prostatic Symptoms Scores (IPSS) & Quality of life (QoL) were compared after one-month period. This study shows a significant decrease in the total IPSS, irritative IPSS, obstructive IPSS and the QoL scores with the administration of tamsulosin. In conclusion: The administration of tamsulosin in patients with ureteral stent is useful in decreasing the ureteral stent related symptoms.","PeriodicalId":52765,"journal":{"name":"Basrah Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of Tamsulosin in the treatment of ureteral stent related symptoms in Basrah General Hospital\",\"authors\":\"Firas S Attar, A. Almayyahi, Ibrahim Mahjar Tuama Flayyih\",\"doi\":\"10.33762/bsurg.2019.164510\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study aimed to evaluate the efficacy of tamsulosin which is an α 1-blocker as a therapeutic agent to alleviate ureteral stent related symptoms. Seventy-two patients were included in this prospective study from August 2018 to August 2019 in Basrah Teaching Hospital. All patients underwent ureteroscopic management of ureteral stones and ureteral stent had been inserted for about one month period. Patients were divided into two groups; a tamsulosin group, and a control group. Then the International Prostatic Symptoms Scores (IPSS) & Quality of life (QoL) were compared after one-month period. This study shows a significant decrease in the total IPSS, irritative IPSS, obstructive IPSS and the QoL scores with the administration of tamsulosin. In conclusion: The administration of tamsulosin in patients with ureteral stent is useful in decreasing the ureteral stent related symptoms.\",\"PeriodicalId\":52765,\"journal\":{\"name\":\"Basrah Journal of Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basrah Journal of Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33762/bsurg.2019.164510\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basrah Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33762/bsurg.2019.164510","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The role of Tamsulosin in the treatment of ureteral stent related symptoms in Basrah General Hospital
This study aimed to evaluate the efficacy of tamsulosin which is an α 1-blocker as a therapeutic agent to alleviate ureteral stent related symptoms. Seventy-two patients were included in this prospective study from August 2018 to August 2019 in Basrah Teaching Hospital. All patients underwent ureteroscopic management of ureteral stones and ureteral stent had been inserted for about one month period. Patients were divided into two groups; a tamsulosin group, and a control group. Then the International Prostatic Symptoms Scores (IPSS) & Quality of life (QoL) were compared after one-month period. This study shows a significant decrease in the total IPSS, irritative IPSS, obstructive IPSS and the QoL scores with the administration of tamsulosin. In conclusion: The administration of tamsulosin in patients with ureteral stent is useful in decreasing the ureteral stent related symptoms.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
